Skip to main content
Fig. 8 | Journal of Biomedical Science

Fig. 8

From: Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP)

Fig. 8

AR immunoreactivity. a Quantification of AR immunoreactivity. b Negative Control. c T8 group. d TC12 group. e TN12 group. f TC16 group. g TN16 group. h TC22(8–12) group. i TN22(8–12) group. j TC22(12–16) group. k TN22(12–16) group. AR-positive staining is indicated by an arrow. Values expressed as media or maximum media values and compared between treated and its respective control group. *p < 0.05; **p < 0.01. Ep = epithelium; St = stroma; L = lumen. Counter-stain: Harris Hematoxylin. 400x, bar = 100 μm

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127